Atlas Trials

Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

Clinical trial NCT02837640 · UNKNOWN

Trial details

NCT number
NCT02837640
Sponsor
Beirut Eye Specialist Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2016-06-01
Primary completion
2017-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.